US pharma major Merck (MSD) dropped India from its list of priority markets. Other top multinational pharma companies have also sounded warning bells about India's IPR regime.
first published: Oct 8, 2013 10:32 pm
A collection of the most-viewed Moneycontrol videos.
Nifty Clocks Triple-Digit Gains After RBI Rate Cut But Logs Losses For The Week| Closing Bell Live
LIVE: RBI Governor Sanjay Malhotra Delivers Key Monetary Policy Statement | Interest Rates & Outlook
Nifty’s Move Hinges On RBI Rate Decision; HUL, ITC Hotels In Focus| Opening Bell Live
Nifty Sideways But Holds 26,000 Ahead Of MPC Rate Decision| IT & Realty Upbeat| Closing Bell Live
